About SQZBiotech
SQZBiotech is a company based in Boston (United States) founded in 2013 was acquired by Stem Cell Technologies in February 2024. SQZBiotech has raised $167.41 million across 16 funding rounds from investors including Boeing, Stem Cell Technologies and HHS. SQZBiotech operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Boston, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sqz Biotechnologies Company
-
Annual Revenue
$21.48 M (USD)-20.74as on Dec 31, 2022
-
Net Profit
-$79.46 M (USD)-15.6as on Dec 31, 2022
-
EBITDA
-$64.14 M (USD)-11.09as on Dec 31, 2022
-
Total Equity Funding
$167.41 M (USD)
in 16 rounds
-
Latest Funding Round
$2 M (USD), Grant
Mar 21, 2022
-
Investors
Boeing
& 21 more
-
Employee Count
Not available
-
Acquired by
Stem Cell Technologies
(Feb 29, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SQZBiotech
SQZBiotech is a publicly listed company on the OTC with ticker symbol SQZB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of SQZBiotech
Unlock access to complete
Funding Insights of SQZBiotech
SQZBiotech has successfully raised a total of $167.41M across 16 strategic funding rounds. The most recent funding activity was a Grant round of $2 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SQZBiotech
SQZBiotech has secured backing from 22 investors, including institutional and venture fund investors. Prominent investors backing the company include Boeing, Stem Cell Technologies and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term private equity investments in transformational opportunities are pursued.
|
Locked | Locked | Locked | |
|
Health tech startups are invested in by Illumina Ventures.
|
Locked | Locked | Locked | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked |
Investor details for SQZBiotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SQZBiotech
Investment portfolio details for SQZBiotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SQZBiotech
Detailed financials for SQZBiotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sqzbiotech Comparisons
Peer comparison for SQZBiotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SQZBiotech
SQZBiotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
Detailed competitors of SQZBiotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sqzbiotech
Complete news archive for SQZBiotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SQZBiotech
SQZBiotech was founded in 2013 and raised its 1st funding round 1 year after it was founded.
SQZBiotech is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
SQZBiotech is a funded company, having raised a total of $167.41M across 16 funding rounds to date.
Annual revenue of SQZBiotech is $21.48M as on Dec 31, 2022.
SQZBiotech was founded in 2013 and is based in Boston, United States. Operations focus on the biotechnology sector, where cell therapies are engineered to address oncology, autoimmune, and infectious diseases. Proprietary Cell Squeeze technology is employed to insert biological materials into diverse cell types, enabling therapeutic applications. A pipeline of treatments is maintained across these disease areas.
SQZBiotech's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Yes, SQZBiotech is publicly traded on OTC under the ticker symbol SQZB.
SQZBiotech has 22 investors. Key investors include Boeing, Stem Cell Technologies, HHS, Temasek, and National Institute of General Medical Sciences.
The ticker symbol of SQZBiotech is SQZB on OTC.